Shalparni: Traditional Uses, Evidence & Safety

TL;DR

Shalparni (Desmodium gangeticum) is a legume-family shrub whose root is a core ingredient of the Dashamoola group of ten herbs, employed in traditional practice for asthma, diabetes, malaria, and hypertension. Research is preclinical: anti-inflammatory, antioxidant, and antimicrobial effects in lab and animal studies. No human trials of shalparni as a single herb were identified, and no established dose exists.

What it is

Shalparni (also spelled salaparni) is Desmodium gangeticum (L.) DC., a shrub in the legume family (Leguminosae/Fabaceae) (PubMed review). It is an essential component of Laghupanchamoola and the broader Dashamoola, the classical Ayurvedic group of ten roots, where it is considered a premier medicinal herb (same review). The same review describes it as an endangered medicinal herb and lists bioactive compounds including gangetin, gangetinin, N,N-tryptamine, and the flavonoids kaempferol and quercetin (same review).

Traditional use

As a Dashamoola ingredient, shalparni root is one of the most widely used herbs in classical Ayurvedic formulations. A 2025 review records its traditional employment for hypertension, diabetes, malaria, and asthma (PubMed review). A second review notes the leaves are used as a galactagogue, leaf poultices for lumbago, and the bark for diarrhea (IJSDR review). These are records of traditional use, not clinical proof.

What modern research says

Preclinical pharmacology

The 2025 chemoprofiling and pharmacology review catalogues a wide range of reported effects, antimicrobial, antioxidant, wound-healing, antifungal, antidiabetic, anticancer, antidiarrheal, antiulcer, anti-inflammatory, antiamoebic, hepatoprotective, nematocidal, and cardioprotective, but these come from laboratory and animal studies, not human trials (PubMed review).

Animal studies

An aqueous decoction of the roots and aerial parts (5, 10, and 20 mg/kg) showed dose-dependent anti-inflammatory and antinociceptive (pain-reducing) activity in rats, inhibiting carrageenan-induced swelling by roughly 15–51% and cotton-pellet granuloma formation by up to about 39% (Desmodium species review). Separately, root extracts at 200 mg/kg were evaluated for antiasthmatic activity in sensitized rats, with reductions in inflammatory markers (same review). These are animal findings; they do not establish effects in people.

Quality and sourcing concern

Shalparni ranks among India's most traded medicinal plant species, and reviews note it is commonly adulterated or substituted in trade with related species such as Desmodium triquetrum and Desmodium velutinum (IJSDR review). Anyone buying shalparni products should look for the Latin binomial Desmodium gangeticum on the label.

What the evidence does not support (yet)

No human clinical trials of shalparni as a single herb were identified in the literature search for this article. Its reputation in respiratory and metabolic conditions rests on traditional use and animal studies.

Dosage

There is no established dose for shalparni as a single herb. No pharmacopoeial or clinical-trial dose was located, so no dose figures are given here. In classical practice it is used within multi-herb formulations such as Dashamoola, under practitioner guidance.

Safety & contraindications

No human safety trials of shalparni were identified. Traditional use within classical formulations has a long history, but that is not a substitute for safety data. Talk to a qualified practitioner before use: especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.

FAQs

What is shalparni?

Shalparni is Desmodium gangeticum, a legume-family shrub whose root is a core ingredient of Dashamoola, the classical Ayurvedic group of ten roots (PubMed review).

What is shalparni used for?

Traditionally it is employed for asthma, diabetes, malaria, and hypertension, and as a core ingredient of Dashamoola formulations; the leaves are also used as a galactagogue and the bark for diarrhea (2025 review; IJSDR review). Modern research has only tested it in laboratory and animal studies: for example, anti-inflammatory effects in rats (Desmodium review).

Are there human trials of shalparni?

No human clinical trials of shalparni as a single herb were identified. All reported pharmacological effects come from preclinical (lab and animal) work.

Is shalparni safe?

No human safety trials exist. It is also one of India's most traded medicinal species and is commonly substituted with related Desmodium species, so product identity matters (IJSDR review). Consult a qualified practitioner before use.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.